{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:59:13Z","timestamp":1771887553090,"version":"3.50.1"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,28]]},"abstract":"<jats:p>\n                    Idiopathic inflammatory myopathies, especially antisynthetase syndrome, often appear outside of the muscles as interstitial lung disease (ILD). Another typical finding is the presence of mechanic\u2019s hands. The aim of the present study was to describe the clinical, functional, tomographic, and serological data of patients with ILD and mechanic\u2019s hands and their response to treatment and survival rates. This is a retrospective study of ILD with concurrent myopathy. Among the 119 patients initially selected, 51 had mechanic\u2019s hands. All the patients were screened for anti-Jo-1 antibodies. An expanded panel of myopathy autoantibodies was also performed in 27 individuals. Of the 51 patients, 35 had 1 or more antibodies. The most common were anti-Jo-1, anti-PL-7, and anti-PL-12, while of the associated antibodies, anti-Ro52 was present in 70% of the 27 tested individuals. A significant response to treatment was characterized by an increase in predicted forced vital capacity (FVC) of at least 5% in the last evaluation done after 6 to 24 months of treatment. A decrease in predicted FVC of at least 5%, the need for oxygen therapy, or death were all considered treatment failures. All patients were treated with corticosteroids, and 71% with mycophenolate. After 24 months, 18 patients had an increase in FVC, 11 had a decrease, and 22 remained stable. After a median follow-up of 58 months, 48 patients remained alive and three died. Patients with honeycombing on high-resolution chest tomography (log-rank\u2005=\u200534.65;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) and a decrease in FVC\u2005\u22655% (log-rank\u2005=\u200518.28,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001) had a poorer survival rate. Patients with ILD and mechanic\u2019s hands respond well to immunosuppressive treatment.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000038642","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T14:58:04Z","timestamp":1719586684000},"page":"e38642","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical profiles and treatment outcomes of outpatients with interstitial lung disease and mechanic\u2019s hands: A retrospective and observational cohort"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1964-8650","authenticated-orcid":false,"given":"Gustavo Frazatto Medeiros de","family":"Miranda","sequence":"first","affiliation":[{"name":"Department of Medicine, Discipline of Pulmonology, Federal University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Raquel","family":"Soares","sequence":"additional","affiliation":[{"name":"Department of Medicine, Discipline of Pulmonology, Federal University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Wagner Silva de","family":"Souza","sequence":"additional","affiliation":[{"name":"Department of Medicine, Discipline of Rheumatology, Federal University of Sao Paulo, Sao Paulo, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Eduardo Coelho","family":"Andrade","sequence":"additional","affiliation":[{"name":"Department of Medicine, Discipline of Rheumatology, Federal University of Sao Paulo, Sao Paulo, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Alberto de Castro","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Medicine, Discipline of Pulmonology, Federal University of Sao Paulo, Sao Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260223","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semarthrit.2020.09.020","article-title":"Antisynthetase syndrome\u2014much more than just a myopathy.","volume":"51","author":"Opinc","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"R2-20260223","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S1806-37132011000100015","article-title":"Myositis-related interstitial lung disease and antisynthetase syndrome.","volume":"37","author":"Solomon","year":"2011","journal-title":"J Bras Pneumol"},{"key":"R3-20260223","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"R4-20260223","doi-asserted-by":"crossref","first-page":"e1144","DOI":"10.1097\/MD.0000000000001144","article-title":"Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study.","volume":"94","author":"Cavagna","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R5-20260223","doi-asserted-by":"crossref","first-page":"e60442","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.","volume":"8","author":"Hamaguchi","year":"2013","journal-title":"PLoS One"},{"key":"R6-20260223","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/1744666X.2019.1699059","article-title":"Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis.","volume":"16","author":"Gono","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"R7-20260223","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0039-1685187","article-title":"Lung diseases in inflammatory myopathies.","volume":"40","author":"Barba","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"R8-20260223","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccm.2019.05.004","article-title":"Interstitial lung disease in polymyositis and dermatomyositis.","volume":"40","author":"Long","year":"2019","journal-title":"Clin Chest Med"},{"key":"R9-20260223","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jaad.2017.10.034","article-title":"Re-examining mechanic\u2019s hands as a characteristic skin finding in dermatomyositis.","volume":"78","author":"Concha","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R10-20260223","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"R11-20260223","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/bjd.14801","article-title":"Clinical signs associated with an increased risk of interstitial lung disease: a retrospective study of 101 patients with dermatomyositis.","volume":"176","author":"Ang","year":"2017","journal-title":"Br J Dermatol"},{"key":"R12-20260223","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies.","volume":"280","author":"Lundberg","year":"2016","journal-title":"J Intern Med"},{"key":"R13-20260223","doi-asserted-by":"crossref","first-page":"e000507","DOI":"10.1136\/rmdopen-2017-000507","article-title":"EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report.","volume":"3","author":"Bottai","year":"2017","journal-title":"RMD Open"},{"key":"R14-20260223","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20260223","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests.","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur Respir J"},{"key":"R16-20260223","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1590\/S1806-37132007000400008","article-title":"New reference values for forced spirometry in white adults in Brazil.","volume":"33","author":"Pereira","year":"2007","journal-title":"J Bras Pneumol"},{"key":"R17-20260223","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1183\/09031936.00094006","article-title":"A step test to assess exercise-related oxygen desaturation in interstitial lung disease.","volume":"29","author":"Dal Corso","year":"2007","journal-title":"Eur Respir J"},{"key":"R18-20260223","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3899\/jrheum.151425","article-title":"Patients with systemic sclerosis\/polymyositis overlap have a worse survival rate than patients without it.","volume":"43","author":"Bhansing","year":"2016","journal-title":"J Rheumatol"},{"key":"R19-20260223","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R20-20260223","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-91-4-577","article-title":"A cutaneous lesion associated with myositis.","volume":"91","author":"Stahl","year":"1979","journal-title":"Ann Intern Med"},{"key":"R21-20260223","doi-asserted-by":"crossref","first-page":"101503","DOI":"10.1016\/j.berh.2020.101503","article-title":"Clinical manifestations and treatment of antisynthetase syndrome.","volume":"34","author":"Marco","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R22-20260223","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s10067-017-3598-5","article-title":"\u201cHiker\u2019s feet\u201d: a novel cutaneous finding in the inflammatory myopathies.","volume":"36","author":"Cox","year":"2017","journal-title":"Clin Rheumatol"},{"key":"R23-20260223","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/BOR.0000000000000434","article-title":"Clinical spectrum of anti-Jo-1-associated disease.","volume":"29","author":"Monti","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"R24-20260223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy.","volume":"52","author":"Satoh","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"R25-20260223","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13613-018-0433-3","article-title":"Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study.","volume":"8","author":"Vuillard","year":"2018","journal-title":"Ann Intensive Care"},{"key":"R26-20260223","doi-asserted-by":"crossref","first-page":"e1416","DOI":"10.1212\/WNL.0000000000007188","article-title":"Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies.","volume":"92","author":"Casal-Dominguez","year":"2019","journal-title":"Neurology"},{"key":"R27-20260223","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2009.09484.x","article-title":"Long-term outcome of patients with polymyositis\/dermatomyositis and anti-PM-Scl antibody.","volume":"162","author":"Marie","year":"2010","journal-title":"Br J Dermatol"},{"key":"R28-20260223","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1756-0500-7-303","article-title":"Mechanic\u2019s hands revisited: is this sign still useful for diagnosis in patients with lung involvement of collagen vascular diseases?","volume":"7","author":"Sohara","year":"2014","journal-title":"BMC Res Notes"},{"key":"R29-20260223","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/thx.2006.069237","article-title":"Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset.","volume":"63","author":"Tillie-Leblond","year":"2008","journal-title":"Thorax"},{"key":"R30-20260223","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-3083.2004.00868.x","article-title":"PM-SCL autoantibody positive scleroderma with polymyositis (mechanic\u2019s hand: clinical aid in the diagnosis).","volume":"18","author":"T\u00f6r\u00f6k","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R31-20260223","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment.","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R32-20260223","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1365-4632.2009.04164.x","article-title":"A histopathologic study of mechanic\u2019s hands associated with dermatomyositis: a report of five cases.","volume":"48","author":"Mii","year":"2009","journal-title":"Int J Dermatol"},{"key":"R33-20260223","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/rheumatology\/kez246","article-title":"Mechanic\u2019s hand: is it a marker of disease relapse?","volume":"59","author":"Kumar","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R34-20260223","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.3390\/jcm12216849","article-title":"Clinical characteristics of anti-synthetase syndrome and variables associated with interstitial lung disease and mortality: a retrospective cohort study.","volume":"12","author":"Sodsri","year":"2023","journal-title":"J Clin Med"},{"key":"R35-20260223","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0889-857X(02)00032-7","article-title":"Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies.","volume":"28","author":"Targoff","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"R36-20260223","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.","volume":"280","author":"Betteridge","year":"2016","journal-title":"J Intern Med"},{"key":"R37-20260223","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1183\/16000617.00002015","article-title":"Idiopathic inflammatory myopathies and the lung.","volume":"24","author":"Lega","year":"2015","journal-title":"Eur Respir Rev"},{"key":"R38-20260223","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","article-title":"Interstitial lung disease in polymyositis and dermatomyositis.","volume":"47","author":"Marie","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R39-20260223","doi-asserted-by":"crossref","first-page":"413","DOI":"10.31138\/mjr.33.4.413","article-title":"Fever, cutaneous ulcers, and arthritis define the MDA5 phenotype in Indian patients with idiopathic inflammatory myositis.","volume":"33","author":"Devarasetti","year":"2022","journal-title":"Mediterr J Rheumatol"},{"key":"R40-20260223","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R41-20260223","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/annrheumdis-2019-215031","article-title":"Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria.","volume":"78","author":"Greco","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R42-20260223","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.21037\/jtd-20-3328","article-title":"A narrative review of interstitial lung disease in anti-synthetase syndrome: a clinical approach.","volume":"13","author":"Sawal","year":"2021","journal-title":"J Thorac Dis"},{"key":"R43-20260223","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ejrad.2014.11.026","article-title":"Interstitial lung disease in anti-synthetase syndrome: initial and follow-up CT findings.","volume":"84","author":"Debray","year":"2015","journal-title":"Eur J Radiol"},{"key":"R44-20260223","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12890-020-01339-9","article-title":"Clinical diagnosis of patients subjected to surgical lung biopsy with a probable usual interstitial pneumonia pattern on high-resolution computed tomography.","volume":"20","author":"Tibana","year":"2020","journal-title":"BMC Pulm Med"},{"key":"R45-20260223","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1440-1843.2008.01363.x","article-title":"Transbronchial biopsy is clinically useful in classifying patients with interstitial pneumonia associated with polymyositis and dermatomyositis.","volume":"13","author":"Mochimaru","year":"2008","journal-title":"Respirology"},{"key":"R46-20260223","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","article-title":"Autoantibodies in myositis.","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R47-20260223","doi-asserted-by":"crossref","first-page":"106581","DOI":"10.1016\/j.rmed.2021.106581","article-title":"Diagnosis of myositis-associated interstitial lung disease: utility of the myositis autoantibody line immunoassay.","volume":"187","author":"Jee","year":"2021","journal-title":"Respir Med"},{"key":"R48-20260223","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3109\/s10165-012-0663-4","article-title":"Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease.","volume":"23","author":"Sato","year":"2013","journal-title":"Mod Rheumatol"},{"key":"R49-20260223","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/BOR.0000000000000329","article-title":"Recent advances in dermatomyositis-specific autoantibodies.","volume":"28","author":"Fujimoto","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"R50-20260223","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","article-title":"Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease.","volume":"121","author":"Hozumi","year":"2016","journal-title":"Respir Med"},{"key":"R51-20260223","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s42358-019-0069-5","article-title":"V Brazilian consensus guidelines for detection of anti-cell autoantibodies on hep-2 cells.","volume":"59","author":"Cruvinel","year":"2019","journal-title":"Adv Rheumatol"},{"key":"R52-20260223","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/art.30084","article-title":"Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.","volume":"63","author":"Mariz","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R53-20260223","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015.","volume":"6","author":"Chan","year":"2015","journal-title":"Front Immunol"},{"key":"R54-20260223","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1196\/annals.1398.047","article-title":"Clinical significance of anti-histidyl-tRNA synthetase (Jo1) autoantibodies.","volume":"1109","author":"Gomard-Mennesson","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R55-20260223","doi-asserted-by":"crossref","first-page":"101769","DOI":"10.1016\/j.berh.2022.101769","article-title":"Management of interstitial lung disease (ILD) in myositis syndromes: a practical guide for clinicians.","volume":"36","author":"Mehta","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R56-20260223","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3899\/jrheum.121026","article-title":"Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.","volume":"40","author":"Cavagna","year":"2013","journal-title":"J Rheumatol"},{"key":"R57-20260223","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/rheumatology\/kev004","article-title":"Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease.","volume":"54","author":"Andersson","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"R58-20260223","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/acr.20212","article-title":"Mycophenolate mofetil for interstitial lung disease in dermatomyositis.","volume":"62","author":"Morganroth","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R59-20260223","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.rmed.2019.05.012","article-title":"Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease.","volume":"154","author":"Huapaya","year":"2019","journal-title":"Respir Med"},{"key":"R60-20260223","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.autrev.2018.07.013","article-title":"Treatment of idiopathic inflammatory myositis associated interstitial lung disease: a systematic review and meta-analysis.","volume":"18","author":"Barba","year":"2019","journal-title":"Autoimmun Rev"},{"key":"R61-20260223","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/rheumatology\/kev192","article-title":"The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.","volume":"8","author":"Kurita","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"R62-20260223","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases.","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"R63-20260223","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"R64-20260223","doi-asserted-by":"crossref","first-page":"2103187","DOI":"10.1183\/13993003.03187-2021","article-title":"Progressive pulmonary fibrosis: an expert group consensus statement.","volume":"61","author":"Rajan","year":"2023","journal-title":"Eur Respir J"},{"key":"R65-20260223","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1513\/AnnalsATS.201807-443OC","article-title":"Computed tomography honeycombing identifies a progressive fibrotic phenotype with increased mortality across diverse interstitial lung diseases.","volume":"16","author":"Adegunsoye","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"R66-20260223","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12890-020-1061-x","article-title":"Impact of radiological honeycombing in rheumatoid arthritis-associated interstitial lung disease.","volume":"20","author":"Yamakawa","year":"2020","journal-title":"BMC Pulm Med"},{"key":"R67-20260223","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1007\/s00330-019-06152-5","article-title":"Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome.","volume":"29","author":"Liu","year":"2019","journal-title":"Eur Radiol"},{"key":"R68-20260223","doi-asserted-by":"crossref","first-page":"106432","DOI":"10.1016\/j.rmed.2021.106432","article-title":"Anti-tRNA synthetase syndrome interstitial lung disease: a single center experience.","volume":"191","author":"Wilfong","year":"2021","journal-title":"Respir Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:02:07Z","timestamp":1771884127000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":68,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038642","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}